Spots Global Cancer Trial Database for stage iii uterine sarcoma

Every month we try and update this database with for stage iii uterine sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma	NCT00390234	Fallopian Tube ... Female Reproduc... Ovarian Carcino... Ovarian Sarcoma Recurrent Ovari... Recurrent Uteri... Stage III Ovari... Stage III Uteri... Stage IV Ovaria... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo...	ziv-aflibercept	18 Years -	National Cancer Institute (NCI)
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus	NCT00002546	Sarcoma	cisplatin ifosfamide adjuvant therap... radiation thera...	21 Years - 120 Years	GOG Foundation
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery	NCT01553539	Bone Cancer Chondrosarcoma Clear Cell Sarc... Metastatic Oste... Ovarian Sarcoma Recurrent Adult... Recurrent Osteo... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin...	therapeutic ang... laboratory biom...	18 Years -	Wake Forest University Health Sciences
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer	NCT00287885	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer	docetaxel	18 Years -	Masonic Cancer Center, University of Minnesota
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer	NCT00112489	Sarcoma	carboplatin paclitaxel	18 Years - 120 Years	GOG Foundation
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma	NCT00053794	Endometrial Can... Sarcoma	perifosine	18 Years - 120 Years	Canadian Cancer Trials Group
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors	NCT00433407	Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu...	trastuzumab	-	Jonsson Comprehensive Cancer Center
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus	NCT00003128	Sarcoma	filgrastim ifosfamide paclitaxel	18 Years -	GOG Foundation
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus	NCT00003128	Sarcoma	filgrastim ifosfamide paclitaxel	18 Years -	GOG Foundation
Chemotherapy in Treating Patients With Advanced Sarcoma	NCT00002526	Ovarian Cancer Sarcoma	filgrastim doxorubicin hyd... ifosfamide	18 Years - 70 Years	Swiss Group for Clinical Cancer Research
Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus	NCT00002993	Sarcoma	cisplatin doxorubicin hyd... mitomycin C	-	GOG Foundation
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer	NCT00003704	Cancer	capecitabine radiation thera...	18 Years -	Alliance for Clinical Trials in Oncology
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus	NCT00379145	Sarcoma	trabectedin	18 Years - 120 Years	GOG Foundation
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer	NCT00087191	Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga...	EF5 motexafin lutet... pharmacological...	18 Years -	National Cancer Institute (NCI)
Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma	NCT00101127	Sarcoma	filgrastim pegfilgrastim docetaxel gemcitabine hyd...	18 Years -	GOG Foundation
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer	NCT00032162	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	carboplatin pegylated lipos...	18 Years -	AGO Study Group
Thalidomide in Treating Patients With Gynecologic Sarcomas	NCT00006005	Endometrial Can... Sarcoma	thalidomide	-	National Cancer Institute (NCI)
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery	NCT01553539	Bone Cancer Chondrosarcoma Clear Cell Sarc... Metastatic Oste... Ovarian Sarcoma Recurrent Adult... Recurrent Osteo... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin...	therapeutic ang... laboratory biom...	18 Years -	Wake Forest University Health Sciences
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer	NCT01098630	Recurrent Cervi... Recurrent Uteri... Recurrent Uteri... Stage I Uterine... Stage I Uterine... Stage IA Cervic... Stage IB Cervic... Stage II Uterin... Stage II Uterin... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Uteri... Stage III Uteri... Stage IV Uterin... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi...	Medical Chart R... Questionnaire A...	-	GOG Foundation
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma	NCT00033709	Sarcoma	temozolomide thalidomide	18 Years -	National Cancer Institute (NCI)
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.	NCT00258401	Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma	dietary interve... management of t... quality-of-life...	20 Years - 80 Years	Case Comprehensive Cancer Center
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.	NCT00258401	Cervical Cancer Diarrhea Prostate Cancer Radiation Toxic... Sarcoma	dietary interve... management of t... quality-of-life...	20 Years - 80 Years	Case Comprehensive Cancer Center
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer	NCT00003704	Cancer	capecitabine radiation thera...	18 Years -	Alliance for Clinical Trials in Oncology
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer	NCT01132547	Cancer	cyproheptadine ... placebo	2 Years - 21 Years	University of South Florida
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer	NCT00003624	Cervical Cancer Endometrial Can... Fallopian Tube ... Neurotoxicity Ovarian Cancer Primary Periton... Sarcoma	amifostine trih... cisplatin paclitaxel	-	GOG Foundation
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma	NCT00002641	Endometrial Can... Kidney Cancer Ovarian Cancer Pheochromocytom... Sarcoma	filgrastim doxorubicin hyd... ifosfamide isolated perfus... adjuvant therap... conventional su... radiation thera...	16 Years - 69 Years	European Organisation for Research and Treatment of Cancer - EORTC
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer	NCT00003624	Cervical Cancer Endometrial Can... Fallopian Tube ... Neurotoxicity Ovarian Cancer Primary Periton... Sarcoma	amifostine trih... cisplatin paclitaxel	-	GOG Foundation
Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer	NCT00383279	Cervical Cancer Ovarian Cancer Sarcoma	counseling inte... study of socioe...	18 Years - 120 Years	Wake Forest University Health Sciences
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer	NCT01764802	Ovarian Sarcoma Ovarian Stromal... Stage I Uterine... Stage I Vaginal... Stage I Vulvar ... Stage IA Cervic... Stage IA Endome... Stage IA Fallop... Stage IA Ovaria... Stage IA Ovaria... Stage IA Primar... Stage IB Cervic... Stage IB Endome... Stage IB Fallop... Stage IB Ovaria... Stage IB Ovaria... Stage IB Primar... Stage IC Fallop... Stage IC Ovaria... Stage IC Ovaria... Stage IC Primar... Stage II Endome... Stage II Gestat... Stage II Uterin... Stage II Vagina... Stage II Vulvar... Stage IIA Cervi... Stage IIA Fallo... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Prima... Stage IIB Cervi... Stage IIB Fallo... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Prima... Stage IIC Fallo... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Prima... Stage III Gesta... Stage III Uteri... Stage III Vagin... Stage III Vulva... Stage IIIA Cerv... Stage IIIA Endo... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Cerv... Stage IIIB Endo... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Endo... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Prim... Breast Cancer	behavioral, psy... behavioral, psy...	21 Years - 80 Years	Ohio State University Comprehensive Cancer Center
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer	NCT00112489	Sarcoma	carboplatin paclitaxel	18 Years - 120 Years	GOG Foundation
Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma	NCT00227669	Sarcoma	docetaxel gemcitabine hyd...	18 Years - 120 Years	UNICANCER
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery	NCT00842452	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer	topotecan hydro... pharmacological...	18 Years -	Case Comprehensive Cancer Center
Thalidomide in Treating Patients With Gynecologic Sarcomas	NCT00006005	Endometrial Can... Sarcoma	thalidomide	-	National Cancer Institute (NCI)
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer	NCT00003704	Cancer	capecitabine radiation thera...	18 Years -	Alliance for Clinical Trials in Oncology
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors	NCT00499291	Cancer	paclitaxel albu... gene expression... laboratory biom... pharmacological... polymerase chai...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma	NCT00245102	Adult Angiosarc... Adult Epithelio... Adult Leiomyosa... Adult Malignant... Adult Neurofibr... Adult Synovial ... Ovarian Sarcoma Recurrent Adult... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo...	sorafenib tosyl...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: